U.S. regulators approve an Alzheimer's drug developed by Japanese drug maker Eisai Co. and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, ...
U.S. regulators approve an Alzheimer's drug developed by Japanese drug maker Eisai Co. and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, ...